SK12662003A3 - Arylsulfónamidy ako antivírusové činidlá - Google Patents

Arylsulfónamidy ako antivírusové činidlá Download PDF

Info

Publication number
SK12662003A3
SK12662003A3 SK1266-2003A SK12662003A SK12662003A3 SK 12662003 A3 SK12662003 A3 SK 12662003A3 SK 12662003 A SK12662003 A SK 12662003A SK 12662003 A3 SK12662003 A3 SK 12662003A3
Authority
SK
Slovakia
Prior art keywords
group
hydroxyl
amino
alkyl
same
Prior art date
Application number
SK1266-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Tobias Wunberg
Wolfgang Bender
Peter Eckenberg
Sabine Hallenberger
Kerstin Henninger
Jrg Keldenich
Armin Kern
Siegfried Raddatz
J�Rgen Reefschl�Ger
Gunter Schmidt
Holger Zimmermann
Franz Zumpe
Martin Radtke
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10148598A external-priority patent/DE10148598A1/de
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of SK12662003A3 publication Critical patent/SK12662003A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SK1266-2003A 2001-04-19 2002-04-08 Arylsulfónamidy ako antivírusové činidlá SK12662003A3 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10119137 2001-04-19
DE10148598A DE10148598A1 (de) 2001-04-19 2001-10-02 Neue Arylsulfonamide als antivirale Mittel
PCT/EP2002/003858 WO2002085869A1 (de) 2001-04-19 2002-04-08 Arylsulfonamide als antivirale mittel

Publications (1)

Publication Number Publication Date
SK12662003A3 true SK12662003A3 (sk) 2004-04-06

Family

ID=26009118

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1266-2003A SK12662003A3 (sk) 2001-04-19 2002-04-08 Arylsulfónamidy ako antivírusové činidlá

Country Status (20)

Country Link
US (1) US7115612B2 (es)
EP (1) EP1383749B1 (es)
JP (1) JP4480941B2 (es)
CN (1) CN1516695A (es)
AT (1) ATE308529T1 (es)
BG (1) BG108272A (es)
BR (1) BR0209054A (es)
CA (1) CA2444123C (es)
DE (1) DE50204780D1 (es)
EE (1) EE200300515A (es)
ES (1) ES2252455T3 (es)
HU (1) HUP0303813A3 (es)
IL (1) IL158324A0 (es)
MX (1) MXPA03009548A (es)
NO (1) NO20034667L (es)
PL (1) PL363990A1 (es)
RU (1) RU2003133750A (es)
SK (1) SK12662003A3 (es)
UY (1) UY27263A1 (es)
WO (1) WO2002085869A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2494164A1 (en) * 2002-08-23 2004-03-04 Rigel Pharmaceuticals, Inc. Pyridyl substituted heterocycles useful for treating or preventing hcv infection
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
UA84420C2 (ru) 2003-04-11 2008-10-27 ПиТиСи ТЕРАПЬЮТИКС, ИНК. СОЕДИНЕНИЯ 1,2,4-ОКСАДИАЗОЛБЕНЗОЙНОЙ КИСЛОТЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ (ВАРИАНТЫ) И ПРИМЕНЕНИЕ СОЕДИНЕНИЙ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ, СВЯЗАННОГО С ПРЕЖДЕВРЕМЕННОЙ ТЕРМИНАЦИЕЙ ТРАНСЛЯЦИИ ИЛИ НОНСЕНС-ОБУСЛОВЛЕННЫМ УМЕНЬШЕНИЕМ мРНК
DE102006009928A1 (de) * 2006-03-03 2007-09-06 Aicuris Gmbh & Co. Kg Substituierte Arylsulfonamide
JP5367563B2 (ja) 2006-03-30 2013-12-11 ピーティーシー セラピューティクス,インコーポレーテッド ナンセンス突然変異を有するdnaからの機能的タンパク質の産生のための方法及びそれと関連した障害の治療
US20080255203A1 (en) * 2007-04-12 2008-10-16 Abbott Laboratories Heterocyclic compounds and their methods of use
CA2692379A1 (en) * 2007-07-02 2009-01-08 Boehringer Ingelheim International Gmbh Antiproliferative compounds based on 5-membered heterocycles
EP2177521A1 (en) * 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
EP2202232A1 (en) * 2008-12-26 2010-06-30 Laboratorios Almirall, S.A. 1,2,4-oxadiazole derivatives and their therapeutic use
WO2012000896A2 (de) * 2010-06-28 2012-01-05 Bayer Cropscience Ag Heterocyclische verbindungen als schädlingsbekämpfungsmittel
US9120752B2 (en) 2010-07-16 2015-09-01 Purdue Pharma, L.P. Pyridine compounds as sodium channel blockers
AU2013203824A1 (en) 2012-03-16 2013-10-03 Purdue Pharma L.P. Substituted pyridines and pryimidines as sodium channel blockers
WO2014070979A1 (en) * 2012-11-03 2014-05-08 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
WO2014070978A1 (en) * 2012-11-03 2014-05-08 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
US9714252B2 (en) 2012-12-20 2017-07-25 Purdue Pharma L.P. Cyclic sulfonamides as sodium channel blockers
CA3174516A1 (en) 2014-03-06 2015-09-11 Ptc Therapeutics, Inc. Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof
EP3256461B1 (en) * 2015-02-13 2023-09-13 Azienda Ospedaliera Universitaria Senese Urea and sulfonamide derivatives as human helicase ddx3 inhibitors useful in the treatment of viral diseases
WO2017075312A1 (en) 2015-10-30 2017-05-04 Ptc Therapeutics, Inc. Methods for treating epilepsy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802437A1 (de) * 1998-01-23 1999-07-29 Bayer Ag Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
PL351374A1 (en) * 1999-04-19 2003-04-07 Shionogi & Co Sulfonamide derivatives having oxadiazole rings

Also Published As

Publication number Publication date
NO20034667D0 (no) 2003-10-17
ES2252455T3 (es) 2006-05-16
JP4480941B2 (ja) 2010-06-16
IL158324A0 (en) 2004-05-12
US20040176374A1 (en) 2004-09-09
EE200300515A (et) 2004-02-16
BR0209054A (pt) 2004-04-20
CN1516695A (zh) 2004-07-28
UY27263A1 (es) 2002-11-29
CA2444123A1 (en) 2002-10-31
EP1383749A1 (de) 2004-01-28
PL363990A1 (en) 2004-11-29
HUP0303813A2 (hu) 2004-03-29
HUP0303813A3 (en) 2005-05-30
RU2003133750A (ru) 2005-05-10
NO20034667L (no) 2003-12-12
CA2444123C (en) 2010-09-21
MXPA03009548A (es) 2004-05-24
JP2004531536A (ja) 2004-10-14
US7115612B2 (en) 2006-10-03
BG108272A (bg) 2004-10-29
ATE308529T1 (de) 2005-11-15
EP1383749B1 (de) 2005-11-02
WO2002085869A1 (de) 2002-10-31
DE50204780D1 (de) 2005-12-08

Similar Documents

Publication Publication Date Title
SK12662003A3 (sk) Arylsulfónamidy ako antivírusové činidlá
ES2312471T3 (es) Compuestos de anillo de 5 miembros que contienen nitrogeno.
CA2865946C (en) Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhibitors
ES2672530T3 (es) Amidas heterocíclicas como inhibidores de cinasas
ES2770026T3 (es) Derivados de imidazotiazol e imidazopirazina como inhibidores del receptor activado por proteasa 4 (PAR4) para tratar la agregación plaquetaria
JP5240899B2 (ja) トリアゾロフタラジン
EP2391602B1 (en) Carbazole carboxamide compounds useful as kinase inhibitors
JP5379132B2 (ja) イミダゾ−、ピラゾロピラジン類およびイミダゾトリアジン類およびそれらの使用
CA2605899C (en) Triazole derivatives as vasopressin antagonists
CA3081399A1 (en) Novel, highly active pyrazolo-piperidine substituted indole-2-carboxamides active against the hepatitis b virus (hbv)
WO2011153588A1 (en) Viral polymerase inhibitors
JP2008501743A (ja) 複素環式抗ウイルス性化合物
CA2608718A1 (en) 1, 2, 4-triazole derivatives as vasopressin antagonists
CA2737894A1 (en) Pyrazolo pyridine derivatives as nadph oxidase inhibitors
KR20040070348A (ko) Hcv 감염 치료용으로 유용한 치환된 디페닐헤테로사이클
AU2014234472A1 (en) 3-acetylamino-1-(phenyl-heteroaryl-aminocarbonyl or phenyl-heteroaryl-carbonylamino)benzene derivatives for the treatment of hyperproliferative disorders
AU2004309164A1 (en) Triazole derivatives as vasopressin antagonists
WO2006030925A1 (ja) 含窒素複素環誘導体およびそれらを有効成分とする薬剤
EA014324B1 (ru) Триазолофталазины
US20100222363A1 (en) Bicyclic Derivatives as P38 Inhibitors
KR20030088509A (ko) 항바이러스제로서의 신규한 아릴술폰아미드
JP2008545756A (ja) 癌化学療法剤として有用な1−メチル−1h−ピラゾール−4−カルボキサミド類
JP5865704B2 (ja) 2−ピリジン−2−イル−ピラゾール−3(2h)−オンの誘導体、この調製および治療的使用
JP2023551197A (ja) ジヒドロイソキノリノン及びイソインドリノン誘導体並びにそれらの使用
CA2456235C (en) Heterocyclylarylsulphonamides

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure